EligibleTrials

Cognitive Neurology Unit Clinical Registry

Recruiting · NCT05925621 · Observational (researchers observe without assigning treatment) · Lead sponsor: Beth Israel Deaconess Medical Center

View the official record on ClinicalTrials.gov →
Alzheimer's disease

Interventions studied

Lecanemab

What this trial is about

A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease

Who can take part

Age range
50 Years to 95 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.